NASDAQ: PROC - Procaps Group S.A.

Rentabilité sur six mois: -54.1%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions Procaps Group S.A.


À propos de l'entreprise Procaps Group S.A.

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products.

plus de détails
In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.

IPO date 2021-09-30
ISIN LU2376511205
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.procapsgroup.com
Цена ао 1.47
Changement de prix par jour: -31.29% (1.47)
Changement de prix par semaine: -31.29% (1.47)
Changement de prix par mois: -4.72% (1.06)
Changement de prix sur 3 mois: -57.02% (2.35)
Changement de prix sur six mois: -54.1% (2.2006)
Changement de prix par an: -65.17% (2.9)
Evolution du prix sur 3 ans: -88.12% (8.5)
Evolution du prix sur 5 ans: -89.85% (9.95)
Evolution des prix depuis le début de l'année: -58.09% (2.41)

Sous-estimation

Nom Signification Grade
P/S 1.33 9
P/BV -289.65 0
P/E 12.79 8
EV/EBITDA 16.9 6
Total: 6.63

Efficacité

Nom Signification Grade
ROA, % 9.22 3
ROE, % -221.9 0
Total: 1.83

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA 6.14 0
Total: 3.8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 27.49 4
Rentabilité Ebitda, % 97.39 9
Rentabilité EPS, % -398.41 0
Total: 2.6



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Ruben Minski Founder & Director N/A 1952 (73 année)
Mr. Patricio Vargas Munoz Global Chief Financial Officer N/A 1973 (52 année)
Dr. Camilo Camacho Chief Operations Officer N/A 1974 (51 année)
Ms. Melissa Angelini Investor Relations Director N/A
Ms. Marcela Carvajalino Pagano Vice-President of Corporate & Legal Affairs N/A 1967 (58 années)
Mr. Luis Alberto Palacios Aragon Vice-President of International Marketing and R&D N/A 1964 (61 année)
Mr. Mauricio Castaneda Caballero Vice-President of Human Resources N/A 1977 (48 années)
Mr. Jose Antonio Toledo Vieira Chief Executive Officer N/A 1966 (59 années)

Adresse: Luxembourg, Luxembourg City, 9 Rue de Bitbourg - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.procapsgroup.com